NasdaqGM - Nasdaq Real Time Price USD

Cronos Group Inc. (CRON)

Compare
2.2600 +0.0600 (+2.73%)
At close: August 30 at 4:00 PM EDT
Loading Chart for CRON
DELL
  • Previous Close 2.2000
  • Open 2.2000
  • Bid --
  • Ask --
  • Day's Range 2.2000 - 2.2700
  • 52 Week Range 1.7000 - 3.1400
  • Volume 630,059
  • Avg. Volume 975,587
  • Market Cap (intraday) 863.955M
  • Beta (5Y Monthly) 1.03
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1500
  • Earnings Date Nov 6, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.86

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

View More

Research Reports: CRON

View More

Performance Overview: CRON

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON
8.13%
S&P/TSX Composite index
11.39%

1-Year Return

CRON
29.89%
S&P/TSX Composite index
15.06%

3-Year Return

CRON
65.12%
S&P/TSX Composite index
13.09%

5-Year Return

CRON
79.57%
S&P/TSX Composite index
42.49%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    858.62M

  • Enterprise Value

    12.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.47

  • Price/Book (mrq)

    0.82

  • Enterprise Value/Revenue

    0.12

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.43%

  • Return on Assets (ttm)

    -3.73%

  • Return on Equity (ttm)

    -5.29%

  • Revenue (ttm)

    101.78M

  • Net Income Avi to Common (ttm)

    -57.37M

  • Diluted EPS (ttm)

    -0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    848.19M

  • Total Debt/Equity (mrq)

    0.19%

  • Levered Free Cash Flow (ttm)

    -30.52M

Research Analysis: CRON

View More

Company Insights: CRON

People Also Watch